Form D — Etheros Pharmaceuticals Corp.
0001999371-25-007554 · filed 2025-06-10
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $600,000
- Total sold
- $600,000
- Minimum investment
- $50,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Etheros Pharmaceuticals Corp.
- CIK
- 2005132
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 111 10TH AVE S
NASHVILLE, TN 37203 - Phone
- 615-212-9695
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John William Scannell · Executive OfficerNashville, TN Find on LinkedIn ↗
-
Marc Feldmann · DirectorNashville, TN Find on LinkedIn ↗
-
Laura Dugan · DirectorNashville, TN Find on LinkedIn ↗
-
Francis Knuettel II · DirectorNashville, TN Find on LinkedIn ↗
-
Subhasish Chakraborty · Executive OfficerNashville, TN Find on LinkedIn ↗
View original on SEC EDGAR.